Dimethylarsinothioyl Glutathione as a Metabolite in Human Multiple Myeloma Cell Lines upon Exposure to Darinaparsin

por Yehiayan, Lucy, Stice, Szabina, Liu, Guangliang, Matulis, Shannon, Boise, Lawrence H., Cai, Yong
Publicado 2014

Alterations in Glutathione Levels and Apoptotic Regulators Are Associated with Acquisition of Arsenic Trioxide Resistance in Multiple Myeloma

por Matulis, Shannon M., Morales, Alejo A., Yehiayan, Lucy, Lee, Kelvin P., Cai, Yong, Boise, Lawrence H.
Publicado 2012

Dexamethasone treatment promotes Bcl-2-dependence in multiple myeloma resulting in sensitivity to Venetoclax

por Matulis, Shannon M., Gupta, Vikas A., Nooka, Ajay K., Von Hollen, Hayley, Kaufman, Jonathan L., Lonial, Sagar, Boise, Lawrence H.
Publicado 2015

BCL2-BH4 antagonist BDA-366 suppresses human myeloma growth

por Deng, Jiusheng, Park, Dongkyoo, Wang, Mengchang, Nooka, Ajay, Deng, Qiaoya, Matulis, Shannon, Kaufman, Jonathan, Lonial, Sagar, Boise, Lawrence H., Galipeau, Jacques, Deng, Xingming
Publicado 2016

β adrenergic signaling regulates hematopoietic stem and progenitor cell commitment and therapy sensitivity in multiple myeloma

por Nair, Remya, Subramaniam, Vimal, Barwick, Benjamin G., Gupta, Vikas A., Matulis, Shannon M., Lonial, Sagar, Boise, Lawrence H., Nooka, Ajay K., Muthumalaiappan, Kuzhali, Shanmugam, Mala
Publicado 2022

A MCP1 fusokine with CCR2-specific tumoricidal activity

por Rafei, Moutih, Deng, Jiusheng, Boivin, Marie-Noëlle, Williams, Patrick, Matulis, Shannon M, Yuan, Shala, Birman, Elena, Forner, Kathy, Yuan, Liangping, Castellino, Craig, Boise, Lawrence H, MacDonald, Tobey J, Galipeau, Jacques
Publicado 2011

Electron transport chain activity is a predictor and target for venetoclax sensitivity in multiple myeloma

por Bajpai, Richa, Sharma, Aditi, Achreja, Abhinav, Edgar, Claudia L., Wei, Changyong, Siddiqa, Arusha A., Gupta, Vikas A., Matulis, Shannon M., McBrayer, Samuel K., Mittal, Anjali, Rupji, Manali, Barwick, Benjamin G., Lonial, Sagar, Nooka, Ajay K., Boise, Lawrence H., Nagrath, Deepak, Shanmugam, Mala
Publicado 2020

Venetoclax sensitivity in multiple myeloma is associated with B-cell gene expression

por Gupta, Vikas A., Barwick, Benjamin G., Matulis, Shannon M., Shirasaki, Ryosuke, Jaye, David L., Keats, Jonathan J., Oberlton, Benjamin, Joseph, Nisha S., Hofmeister, Craig C., Heffner, Leonard T., Dhodapkar, Madhav V., Nooka, Ajay K., Lonial, Sagar, Mitsiades, Constantine S., Kaufman, Jonathan L., Boise, Lawrence H.
Publicado 2021

Therapeutic implications of mitochondrial stress–induced proteasome inhibitor resistance in multiple myeloma

por Sharma, Aditi, Nair, Remya, Achreja, Abhinav, Mittal, Anjali, Gupta, Pulkit, Balakrishnan, Kamakshi, Edgar, Claudia L., Animasahun, Olamide, Dwivedi, Bhakti, Barwick, Benjamin G., Gupta, Vikas A., Matulis, Shannon M., Bhasin, Manoj, Lonial, Sagar, Nooka, Ajay K., Wiita, Arun P., Boise, Lawrence H., Nagrath, Deepak, Shanmugam, Mala
Publicado 2022

Venetoclax ex vivo functional profiling predicts improved progression-free survival

por Gupta, Vikas A., Matulis, Shannon M., Barwick, Benjamin G., Bog, R. Devin, Shebelut, Conrad W., Shanmugam, Mala, Neri, Paola, Bahlis, Nizar J., Dhodapkar, Madhav V., Heffner, Leonard T., Hofmeister, Craig C., Joseph, Nisha S., Lonial, Sagar, Kaufman, Jonathan L., Jaye, David L., Nooka, Ajay K., Boise, Lawrence H.
Publicado 2022

Discovery of Mcl-1-specific inhibitor AZD5991 and preclinical activity in multiple myeloma and acute myeloid leukemia

por Tron, Adriana E., Belmonte, Matthew A., Adam, Ammar, Aquila, Brian M., Boise, Lawrence H., Chiarparin, Elisabetta, Cidado, Justin, Embrey, Kevin J., Gangl, Eric, Gibbons, Francis D., Gregory, Gareth P., Hargreaves, David, Hendricks, J. Adam, Johannes, Jeffrey W., Johnstone, Ricky W., Kazmirski, Steven L., Kettle, Jason G., Lamb, Michelle L., Matulis, Shannon M., Nooka, Ajay K., Packer, Martin J., Peng, Bo, Rawlins, Philip B., Robbins, Daniel W., Schuller, Alwin G., Su, Nancy, Yang, Wenzhan, Ye, Qing, Zheng, Xiaolan, Secrist, J. Paul, Clark, Edwin A., Wilson, David M., Fawell, Stephen E., Hird, Alexander W.
Publicado 2018